Initial headlines led with their mRNA jab being 70 percent effective, but in reality, the results have more nuance.
Phase three interim analysis of the vaccine found it was 70.4 percent effective when “combining data from two dosing regimens”.
But the researchers explored results of more than one regimen, and each turned out new findings.
They found one other regimen had 62 percent effectiveness, while a third had up to 90 percent.
Source: Daily Express